CSPC Pharmaceutical Group Ltd
CSPC Pharmaceutical Group's GHG Emissions Data Preview
In 2024, CSPC Pharmaceutical Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, CSPC Pharmaceutical Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind CSPC Pharmaceutical Group’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CSPC Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.
Insights into CSPC Pharmaceutical Group's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of CSPC Pharmaceutical Group amounted to 967,877.04 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of CSPC Pharmaceutical Group decreased by 10.49%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
CSPC Pharmaceutical Group's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are CSPC Pharmaceutical Group's Scope 1 emissions?
In 2024, the total Scope 1 emissions of CSPC Pharmaceutical Group were 474,567.04 metric tons of CO₂ equivalent (tCO₂e). a
Has CSPC Pharmaceutical Group reduced its Scope 1 emissions over time?
Since 2020, CSPC Pharmaceutical Group's Scope 1 emissions have increased by 36.07%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), CSPC Pharmaceutical Group's Scope 1 emissions decreased by 28.45%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are CSPC Pharmaceutical Group's Scope 2 emissions?
In 2024, CSPC Pharmaceutical Group reported Scope 2 greenhouse gas (GHG) emissions of 493,310 tCO₂e without specifying the calculation method. a
Has CSPC Pharmaceutical Group reduced its Scope 2 emissions over time?
Since 2020, CSPC Pharmaceutical Group's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 29.41%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2023), CSPC Pharmaceutical Group's Scope 2 emissions (Unspecified Calculation Method) rose by 18.01% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does CSPC Pharmaceutical Group use for Scope 2 reporting?
In 2024, CSPC Pharmaceutical Group reported its Scope 2 emissions using an unspecified methodology. a
CSPC Pharmaceutical Group's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into CSPC Pharmaceutical Group’s GHG Emissions Intensity Compared to Industry Peers
In 2024, CSPC Pharmaceutical Group reported Scope 1 greenhouse gas (GHG) emissions of 474,567.04 tCO₂e and total revenues of USD 4,327 millions. This translates into an emissions intensity of 109.67 tCO₂e per millions USD. a
CSPC Pharmaceutical Group's Scope 1 Emissions Intensity Compared to Peers
How does CSPC Pharmaceutical Group's GHG emissions intensity compare to its peers?
In 2024, CSPC Pharmaceutical Group reported a Scope 1 emissions intensity of 109.67 tCO₂e per millions USD. Compared to the peer group median of 4.91 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does CSPC Pharmaceutical Group rank on GHG emissions intensity within its industry?
In 2024, CSPC Pharmaceutical Group ranked 24 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places CSPC Pharmaceutical Group among the least efficient performers, with one of the highest emissions intensities in its sector. a